Health Bulletin 14/September/2022 Roshni Dhar14 Sept 2022 5:53 PM ISTHere are the top health news for the day:No HC relief to doctor accused of performing forcible sex change surgery on minor after kidnapping him The...
Use of insulin glargine in type 1 diabetes tied to reduced time in hypoglycemia after exercise: Study Medha Baranwal11 Jun 2022 10:15 AM ISTAustria: People with type 1 diabetes receiving insulin glargine U-300 (IGlar U300) had a significantly lower time spent in hypoglycemia after...
Tirzepatide Slows CKD Progression among diabetes patients with Increased CV risk Dr. Kamal Kant Kohli7 Jun 2022 9:15 AM ISTTirzepatide can slow progression of chronic kidney disease in type 2 diabetes according to an analysis of SURPASS-4 data presented at ADA 2022. In...
Sanofi Gets CDSCO panel okay for retrospective study of Insulin Glargine Dr. Divya Colin2 April 2022 6:05 PM ISTNew Delhi: Pharmaceutical major, Sanofi has got the go-head from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Biocon Biologics, Viatris to offer Insulin Glargine by Walgreens Prescription Savings Club Ruchika Sharma20 Nov 2021 2:14 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. have confirmed that Insulin Glargine (insulin glargine-yfgn)...
Biocon Biologics, Viatris launch interchangeable biosimilars Semglee, Insulin Glargine injections in US Ruchika Sharma17 Nov 2021 11:30 AM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. today announced the U.S. launch of interchangeable biosimilars SEMGLEE...
Insulin degludec has lower rates of nocturnal hypoglycaemia in T1D compared to insulin glargine: Study MD Editorial Team22 Oct 2021 11:00 AM ISTNocturnal hypoglycemia is a serious complication of insulin-treated diabetes, which commonly goes undetected. Patients with T1D have lower...
Sanofi gets CDSCO panel marketing authorization for Insulin Glargine Medical Dialogues Team3 Oct 2021 11:30 AM ISTNew Delhi: Approving the waiver of additional requirements for local clinical trials in the country, the Subject Expert Committee (SEC) functional...
Sanofi plea for Insulin Glargine, Lixisenatide antidiabetic combination rejected by CDSCO panel Medical Dialogues Team16 Sept 2021 4:14 PM ISTNew Delhi: In a major setback to Sanofi India Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Biocon Biologics, Viatris get USFDA nod for first interchangeable biosimilar Semglee for diabetes Ruchika Sharma29 July 2021 1:33 PM ISTThe interchangeable Semglee product, which will allow substitution of Semglee for the reference product, Lantus, at the pharmacy counter, will be...
Biocon net profit declines 23 percent at Rs 195 crore in Q2 Ruchika Sharma25 Oct 2020 9:45 AM ISTNew Delhi: Biotechnology major Biocon on Friday reported a 23.01 per cent fall in its consolidated net profit to Rs 195.4 crore for the second quarter...
Semglee now available for better blood sugar control in diabetes Dr Satabdi Saha3 Sept 2020 4:56 PM ISTSemglee (Insulin glargine) injection a long-acting human insulin analogue is now available in US to improve blood sugar control in adults and...
